egt & SEHTA host 2nd webinar series on In-Vivo Devices, Microfluidics & Diagnostics

11th August 2020

***we regret to inform you that Due to unforeseen circumstances, this webinar series will be postponed.***

we hope to be able to reschedule in the near future. if you would like to be kept informed as to our upcoming webinars or would like to register your interest for the rearranged date, please contact Lois Dixon.



Following the success of our inaugural webinar series which focused on medical devices, eg technology are once again teaming up with SEHTA to host a series of three webinars dedicated to the design and development of In-vivo devices, Microfluidics and Diagnostics.

Set across three consecutive days, each webinar will be run by an egt director, who is an expert in their field. We hope these valuable insights will enable registrants to update their skillsets within these specific areas and help drive medical technologies and companies forward.

Registration is limited so don’t miss out and remember to join SEHTA, free of charge, as a member for discounted webinar prices.


The Killer Issue: How to mitigate risk when designing in-vivo devices

15th September | 2-3pm
Danny Godfrey | egt co-founder / director

Risk goes hand in hand with medical device design and development – intervening in the human body will always have the potential to go wrong. But what happens when device limitations could result in serious injury or even death? Join egt director, Danny Godfrey as he looks specifically at the design and development of in-vivo devices and how risks are identified, managed, and mitigated to minimize the risk of potentially catastrophic outcomes. Starting with a brief overview of the medical device development process, this webinar will address the importance of examining the full use cycle of your device and identifying risks early on in your project – including less obvious and sometimes unseen obstacles – whilst ensuring full traceability throughout.

You will learn:

  • The key things to consider from the outset of any development programme
  • How to identify the full spectrum of potential risks
  • When in your programme this should happen
  • The importance of device classification and mapping risks against standards
  • How to mitigate risks to allow you to get on with your design 


Microfluidics; small technology, big pitfalls

16th September | 2-3pm
Andrew Ede | egt co-founder / director

It is estimated that the Global Microfluidics Market will have a value of over USD 53 billion by the end of 2027, but how much do you really know about Microfluidics and how it fits in to a design programme? This webinar will look at the various development challenges when working with Microfluidics.

Starting with an overview of applications and fabrication technologies, we will then discuss the relationship between single use consumables and multi-use products with examples, the different fluid handling technologies and then move on to the main developmental obstacle; identifying, assessing and overcoming the many pitfalls associated with Microfluidics.

This webinar will cover:   

  • An overview of Microfluidics and how it is incorporated into development programmes
  • Understanding the different technologies available and identifying the most suitable option for your programme
  • The importance of identifying and assessing risks early in your programme and overcoming these development challenges


Diagnosing the risk in diagnostics development; man versus machine

17th September | 2-3pm
David Warwick | egt director

The design and development of Diagnostic devices within the medical industry is a complex process, fraught with usability uncertainties. Many clinicians are reluctant to make a diagnosis without the confirmation of a device, but devices cannot always be used in isolation as they do not have the full picture and patient knowledge of the clinician. This dichotomy makes the development of such devices often difficult. So, how do we develop a diagnostics device which satisfies the product, patient, and clinician requirement specifications? Furthermore, how can we develop a diagnostics strategy that addresses the co-dependence of diagnostic devices and their user?

This webinar will focus on what it takes to produce a diagnostics device which not only meets requirements but lives up to its marketing. Looking at the user and usability requirements, how your device should be classified and the importance of creating a defined strategy, we will discuss the human factors involved with diagnostics design and how total reliance on the device is not always the best option.

Topics to be covered include:

  • The key considerations in a diagnostics device development programme
  • The importance of identifying your product strategy early in your programme
  • How to keep usability and the end-user in mind throughout
  • Navigating the regulatory process
  • Closing the design loop – ensuring your end product does what you say it does!

For more information or to chat to one of our team about your medical device product design and development process, please do not hesitate to get in touch:

via email on

by giving us a call on +44 01223 813184

or by clicking here  


Industrial Design | Mechanical | Human factors | Electronic and Software Engineering | Project Management | Quality Assurance. 


Related News